Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading medical technology company, has announced that its management team will present at the prestigious 35th Annual Piper Sandler Healthcare Conference on …
Neuronetics to Showcase at the 35th Annual Piper Sandler Healthcare Conference Read More MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) announced this week significant updates to its proprietary NeuroStar software and TrakStar® Patient Data Management System. These enhancements aim to revolutionize patient care …
Neuronetics Unveils Major Updates to NeuroStar and TrakStar Software for Enhanced Patient Care and Data Management Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), the makers of NeuroStar Advanced Therapy, recently announced vital healthcare policy updates from Magellan, BlueCross BlueShield (BCBS) of Kansas City, and Dean Health …
Neuronetics Gets Healthcare Policy Boost: Increased Patient Access to NeuroStar Therapy Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a pioneer in the treatment of psychiatric disorders, announced its financial and operating results for the third quarter of 2023 this week. The …
Neuronetics Reports 8% Revenue Growth in Q3 2023, Expects Continued Momentum Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced the granting of inducement awards of Restricted Stock Units representing a total of 18,000 shares of the Company’s common stock …
Neuronetics Grants Restricted Stock Units as Inducement Awards Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that it plans to release third quarter 2023 financial and operating results prior to market open on Tuesday, November 7th, 2023. The …
Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced that clinical findings from the NeuroStar Outcomes Registry are published in the premier journal in the field of neuromodulation, Brain …
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), in recognition of National Suicide Prevention Awareness Month, announced the launch of the NeuroStar Voices Portal, a platform aimed at fostering connections, sharing …
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced NeuroStar Advanced Therapy’s “Tap Into A New Possibility for Depression” campaign has been awarded Gold by the 2023 dotCOMM Awards …
NeuroStar Advanced Therapy Shines Bright, Triumphs at 2023 dotCOMM Awards Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company, this week announced enhancements to the TrakStar® Patient Data Management System, a proprietary, HIPAA-compliant, patient management and outcomes reporting …
Neuronetics Unveils Enhanced TrakStar Patient Data Management System, Revolutionizing NeuroStar TMS Experience Read More